SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ORTC Ortec International

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LTK007 who wrote (217)12/17/1998 10:16:00 PM
From: Tummus1  Read Replies (2) of 272
 
max90

I got this off of the Yahoo board:

"There is an analyst for Wedbush Morgan securities that is supposed to do
an analysis of the Wound Care sector every six months. He is next due in
December.

Maybe he has something positive to say and has already released the news
to his clients. That is the only thing that I can think of.

The major milestone that ORTC has due is the implementation of a
cryopreservation technique for its product. "

I believe that jake on this thread may have posted it there but not sure. Also I have heard a rumor about a Johnson and Johnson buyout. But that is all I have heard. I am not putting too much thought into that however. As for G. Soros, that is why I got interested in ORTC in the first place. That's about all I know. I would point out that ATIS, before it got a hard time from the FDA, had a market cap 8x of ORTC and ORG's is currently also 8x more. They are both developing comparable technology. I am not saying that ORTC is going up 8x but that it might at least have a little wiggle room.
TW
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext